IFNG and neoplasm: We now know that when native hemocyanins are inoculated, they induce a robust Th1-type immune response against them, exerting a bystander activator effect in neighboring cells, breaking tumor tolerance and favoring latent immune reactions occurring in an individual, augmenting IFNg-production, and enhancing in vivo antitumor activity [90,91] (Figure 3).